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Executive Summary 2013
The annual publication of the Massachusetts STD, HIV/AIDS, and Viral Hepatitis
Surveillance Report provides an occasion to reflect upon trends in these diseases
within the Commonwealth of Massachusetts
In 2013, the following trends in the three most commonly reported bacterial STIs in
Massachusetts were observed:
• Infectious syphilis (primary, secondary, and early latent syphilis) incidence 
rates continued to increase yearly to a ten-year high of 10.5 per 100,000.
Although infectious syphilis remains relatively uncommon overall, 
compared to historical incidence rates, the infection remains at epidemic 
levels among men who have sex with men.
• The total number of gonorrhea cases increased in 2013 by 18%, with a 
25% increase in the number of gonorrhea cases among males. Gonorrhea
continues to affect non-white populations living in major urban centers 
disproportionately.
• Chlamydia cases have plateaued with about 23,000 cases reported in 
each of the past three years (2011 to 2013). Case ascertainment is 
reflective of access to screening with more sensitive laboratory testing 
and/or increased utilization of electronic laboratory reporting. Moreover, 
there are gaps in our understanding of what proportion of chlamydia cases 
will progress to complications, such as epididymitis, pelvic inflammatory 
disease, ectopic pregnancy, infertility, or chronic pelvic pain.1
Regarding HIV/AIDS, notable trends in 20122 included the following:
• The number of persons known to be living with HIV/AIDS in Massachusetts
increased to over 18,000 in 2012 due to newly reported infections and 
because survival continued to improve.
• Black and Hispanic/Latino residents have significantly higher rates of HIV 
infection compared to white residents.
• Male-to-male sex remains the single most frequently identified exposure 
mode among newly diagnosed HIV infection cases.
With regard to viral hepatitis, we observed the following trends in 2013:
• Confirmed new cases of chronic hepatitis B continued to decline, a trend due 
in large part to near universal immunization of children against hepatitis B.
Given that the highest risk population for chronic hepatitis B infection is 
immigrants from endemic countries, any shifts in testing access for this 
population could also influence the numbers of reported cases.
• There has been an overall decline in the number of newly diagnosed hepatitis 
C cases reported in Massachusetts since 2004. However, with an average of 
over 5,500 cases reported in each of the past ten years (2004 to 2013), 
hepatitis C remains one of the highest volume reportable infections. Despite 
the overall decline in newly reported cases, there continues to be an increase 
of hepatitis C cases reported among adolescents and young adults, reflecting 
ongoing transmission among young people injecting drugs in the state.
1 Gottlieb SL. Summary: the natural history and immunobiology of Chlamydia trachomatis genital infection and 
implications for chlamydia control. Journal of Infectious Diseases 201:S190-204, 2010.
2 Due to reporting delays related to site-specific reporting issues, all HIV/AIDS data reflect HIV diagnosed through 2012.
Highlighted on pages 16–23 are trends within special populations disproportionally 
affected by STIs, HIV/AIDS, and/or viral hepatitis. Massachusetts data are reflective
of a number of national trends among women, minorities (both sexual and racial/ethnic
minorities), and youth. Where we differ is in disparities observed in reported STIs
among certain racial/ethnic and sexual minorities. It remains to be determined
whether this reflects improved access to care leading to more screening and 
identification of infection, true increases in infection within certain minority populations,
or true decreases in infection within non-minority populations. Improvements in 
reporting systems, which provide more complete information on other possible risk
and protective associations, are critical for improving our understanding of disparities
in reportable diseases. 
The focus of this annual surveillance report is necessarily on diseases reportable 
to the state and cannot explore all social and behavioral determinants of health.
However, it should be recognized that sexually transmitted infections, including
HIV/AIDS and viral hepatitis, occur at the nexus of individual human behavior, 
community risk, clinical diagnosis and treatment, and public health prevention and
control. The intended audience for this annual surveillance report includes the 
clinicians and the laboratory professionals who report these cases, as well as the
community organizations, local public health departments, policymakers, and 
researchers who are interested in the sexual health and well-being of residents of 
the Commonwealth of Massachusetts. We welcome feedback, and invite you, the
reader, to begin by thinking in terms of disease statistics, but end by acting in terms
of health promotion.
Daniel Church, MPH, Viral Hepatitis Coordinator, Division of Epidemiology 
and Immunization
Katherine Hsu, MD, MPH, Medical Director, Division of STD Prevention and
HIV/AIDS Surveillance
Betsey John, MPH, Director, HIV/AIDS and STD Surveillance
Brenda Cole, MEd, Director, Division of STD Prevention
H. Dawn Fukuda, ScM, Director, Office of HIV/AIDS
Patricia Kludt, MPH, Director, Epidemiology Program 
Larry Madoff, MD, Director, Division of Epidemiology and Immunization
Alfred DeMaria, Jr., MD, Medical Director and State Epidemiologist, 
Bureau of Infectious Disease 
Kevin Cranston, MDiv, Director, Bureau of Infectious Disease 
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In 2013, there were 23,579 reported chlamydia
cases in Massachusetts, making chlamydia the
most reported infection in the Commonwealth.
Chlamydia infection is widely distributed in
Massachusetts. There were no major shifts in
the geographic distribution of cases within the
state in the past year.
Additional information about chlamydia infection
and other STIs is available online at
www.mass.gov/dph/cdc/std.
The overall Massachusetts chlamydia incidence
rate of 352 per 100,000 is lower than the national
rate of 457 per 100,000.3 Massachusetts ranked
10th lowest in chlamydia incidence rate among
the 50 states. The five highest chlamydia 
incidence rates were in Provincetown,
Lawrence, Springfield, Boston, and Brockton. 
Throughout the state, the majority of cities 
and towns fall into the 50 to 200 cases per
100,000 population range.
The total number of reported chlamydia cases
in Massachusetts has nearly doubled in the
past ten years, from 13,131 in 2004 to 23,579
in 2013. 
There was a 2% decrease in the number of
cases reported in 2013 compared to 2012.
Of the total reported cases in 2013, 7,416
(31%) were in men, and 16,140 (69%) were 
in women. The greater number of chlamydia
cases among women is a combined effect 
of increased incidence and a higher level of
screening of women.
3 Please note all national STD rates cited are from 2012; Centers for Disease Control and Prevention. Sexually Transmitted
Disease Surveillance 2012. Atlanta: U.S. Department of Health and Human Services; 2014.
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Across age groups, chlamydia incidence rate has
remained highest among adolescents and young
adults from 2004 to 2013. In 2013, the chlamydia
incidence rate in Massachusetts among 
adolescents (ages 15-19) was 1,093 per 100,000
compared to 2,002 nationally. The rate among
young adults (ages 20-24) in Massachusetts was
2,073 cases per 100,000 compared to 2,502 
nationally. For the first time in ten years, there was
a decrease in the incidence rate among both the
youngest age groups in 2013 compared to 2012.
The chlamydia incidence rate decreased by 14%
among adolescents (ages 15-19) and by 2%
among young adults (ages 20-24). It remains to 
be seen if this one-year change in rate will be an
ongoing trend.
Historically, members of communities of color have
been disproportionately affected by STIs. In 2013,
compared to the white population, the incidence rate
of reported chlamydia infection in Massachusetts
was seven times higher in the black and four times
higher in the Hispanic/Latino population. Disparities
in the chlamydia incidence rate in Massachusetts
have decreased in recent years. In 2004, the
chlamydia incidence rate was 12 times higher in the
black and eight times higher in the Hispanic/Latino
population, compared to the white population. Since
2008, changes in electronic reporting of laboratory
results indicating STI cases to MDPH resulted in an
increased proportion of STI cases being categorized
as “other” race. Thus, as of 2008, increases in the
rate of STIs in the “other” category may be related 
to electronic reporting rather than increase in 
incidence in these populations. Please note that
cases with unknown race/ethnicity, which account
for an average of 34% of chlamydia cases 
diagnosed from 2004 to 2014, are no longer 
included in this analysis.
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CHLAMYDIA SCREENING PROJECTS
Since 1997, the Division of STD Prevention has worked to reduce infertility and other health 
consequences of chlamydia infection through screening and treatment of women who are at higher
risk for infection.
In 2013, 11,171 specimens were tested for chlamydia infection in females and males. Eight percent
were positive. 7,522 of these specimens were also tested for gonorrhea, of which 1% were 
positive. Test results from participating sites have yielded the following: 
CHLAMYDIA SCREENING PROJECTS, PERCENT POSITIVE 
FOR CHLAMYDIA INFECTION AMONG FEMALES, MASSACHUSETTS 2013
SITE TYPE NUMBER TESTED % POSITIVE
School-Based Health Centers (N = 1,128) 7%
Correctional Facilities (N = 563) 3%
Family Planning Clinics (N = 5,082) 6%
Expanded STD Screening Sites* (N = 2,900) 9%
Data Source: MDPH Bureau of Infectious Disease
*Includes females under age 26 years, tested at Prevention, Integrated Counseling, Screening, and Referral sites under IPP.
EXPEDITED PARTNER THERAPY
The MDPH promulgated regulations in August 2011 to permit clinicians to prescribe or dispense 
antibiotic treatment for the partners of persons with chlamydia infection without having to examine
the partner, known as Expedited Partner Therapy (EPT). In January 2012, the chlamydia case report
form was modified to capture information regarding partner notification and treatment including EPT.
EPT is underutilized and underreported in Massachusetts relative to the need for this intervention
and the likely pattern of provider prescribing of EPT. An analysis of laboratory-confirmed chlamydia
cases in 2013 revealed that only 35% of cases had complete partner notification information 
and 25% had complete partner therapy information. Of those, 91% of providers reported partner 
notification, mainly via patient notification of partners. Providers offered EPT in 27% of cases (of the
25% with complete partner therapy information); of those, 49% used patient-delivered prescriptions
only; 47% used patient-delivered medications; and 3% reported using a combination of methods; 
7% reported that partners were treated in the provider’s office. Community health centers 
and school-based clinics reported using EPT in a larger proportion of patients compared to other
clinical settings.
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The number of gonorrhea cases in 
Massachusetts in 2013 was 3,151, an 18% 
increase from the previous year. Cases are 
far more common in urban locations.
Additional information about gonorrhea 
and other STIs is available online at
www.mass.gov/dph/cdc/std.
The Massachusetts gonorrhea incidence rate
of 47 per 100,000 is less than half the national
rate of 108 per 100,000.4 Massachusetts
ranked ninth lowest in gonorrhea incidence rate
among the 50 states. Incidence is clustered
around urban areas, with the five highest rates
in Provincetown, Boston, Chelsea, Brockton, 
and Springfield.
From 2004 to 2013, the number of gonorrhea
cases fluctuated with both increases and 
decreases year-to-year and over the ten-year
period. After declining from 3,039 cases in
2004 to 1,918 cases in 2009, the number of
gonorrhea cases increased to 3,151 in 2013.
4 Please note all national STD rates cited are from 2012; Centers for Disease Control and Prevention. Sexually Transmitted
Disease Surveillance 2012. Atlanta: U.S. Department of Health and Human Services; 2014.
GO
NO
RR
HE
A
Page 7
From 2004 to 2009, the number of gonorrhea
cases reported among males was about the
same as the number reported among females.
From 2010 to 2013, more cases were reported
among males than females (males accounted for
an average of 59% of cases and females 41%). 
From 2004 to 2013, the gonorrhea incidence rate
per 100,000 was highest among young adults
ages 20 to 24 years (205 per 100,000 in 2013). 
In 2013, the gonorrhea incidence rate among
young adults (ages 20 to 24 years old) was four
times the state-wide incidence rate; among 25 to
29 year olds (141 per 100,000) it was three times
the state-wide incidence rate (47 per 100,000). 
In 2013, in Massachusetts, the reported 
gonorrhea incidence rate was 11 times higher 
in the black population (195 cases per 100,000)
and three times higher in the Hispanic/Latino
population (61 cases per 100,000) compared 
to the white population (18 cases per 100,000).
In 2008, changes in electronic reporting of 
laboratory results indicating STI cases to 
MDPH resulted in an increased proportion of
STI cases being categorized as “other” race.
Thus, as of 2008, increases in the rate of 
STIs in the “other” category may be related to
electronic reporting. Please note that cases 
with unknown race/ethnicity, which accounted
for an average of 25% of gonorrhea cases 
diagnosed from 2004 to 2013, are no longer 
included in this analysis.
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In 2013, there were 701 infectious syphilis cases
(primary, secondary, and early latent) reported in
Massachusetts. Although infectious syphilis
cases have been reported in almost all counties,
39% of the cases were reported in Suffolk
County, 21% were reported in Middlesex County
and 10% were reported in Hampden County.
Additional information about infectious syphilis
is available online at
www.mass.gov/dph/cdc/std.
In 2013, the infectious syphilis incidence rate
for Massachusetts was 11 per 100,000. This
represents the highest infectious syphilis rate
in the past ten years. By county, the highest 
infectious syphilis rates were in Suffolk (38 
per 100,000 and Hampden (16 per 100,000); 
followed by Middlesex and Hampshire (at 10
per 100,000 and 9 per 100,000, respectively).
Barnstable, Worcester, Essex, Norfolk, Bristol,
Plymouth, Franklin and Berkshire Counties
had syphilis rates less than seven per 100,000
and Dukes and Nantucket Counties had rates
that were suppressed for confidentiality.
In Massachusetts, the male-to-female ratio of
infectious syphilis cases increased from 3:1 in
2004, to 19:1 in 2009, then decreased to 12:1
in 2013. The elevated male-to-female ratio 
reflects an increase in the number of infectious
syphilis cases diagnosed in men who have 
sex with men. Although the number of reported
female cases is much smaller than male, it has
more than doubled in the past five years from
2009 (N=19) to 2013 (N=55).
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In 2013, the infectious syphilis rate per 
100,000 was highest among 25 to 29 year 
olds (24 per 100,000), followed by 30 to 39 
year olds (23 per 100,000). In 2013, the 
infectious syphilis incidence rate among both 
25 to 29 year olds and 30 to 39 year olds was
more than double the overall incidence rate 
of 11 per 100,000. 
In 2013, the infectious syphilis incidence rate was
three times higher in both the black population
(25 cases per 100,000) and Hispanic/Latino 
population (22 cases per 100,000) compared 
to the white population (7 cases per 100,000).
Please note that cases with unknown race/
ethnicity, which accounted for an average of 6%
of infectious syphilis cases diagnosed from 2004
to 2013, are no longer included in this analysis.
SYPHILIS IN MEN WHO HAVE SEX WITH MEN (MSM)
In Massachusetts, MSM represent a higher-risk group for infectious syphilis. Of the 701 infectious
syphilis cases in 2013, 536 (76%) were reported in MSM. Forty-three percent (N=232) of the MSM
with infectious syphilis disclosed that they were co-infected with HIV. Forty-two percent of the 
infectious syphilis cases in MSM were reported in Suffolk County and 21% were reported in 
Middlesex County. 
Transmission of syphilis can occur between men through unprotected oral and anal sex. Additional
information and resources regarding MSM and STIs is available online at 
http://www.mass.gov/eohhs/gov/departments/dph/prog-a-j/bcdc/factsheets.html.
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Of the 351 cities and towns in Massachusetts,
203 (58%) had at least one reported HIV 
infection diagnosis from 2010 to 2012. The
majority of HIV infection diagnoses were 
reported in people living in large urban areas.
Regional, statewide and population based
HIV/AIDS data are available online through
the MDPH HIV/AIDS Epidemiologic Profile at:
www.mass.gov/eohhs/gov/departments/dph/
programs/id/hiv-aids/epi-profile/
Of those cities and towns where HIV infections
were diagnosed within the three-year period
2010 to 2012, the majority (75%) had rates
under 10 per 100,000 population.
Provincetown had the highest rate of HIV 
infection diagnosis at 306 per 100,000 
population.
In 2012, there were 694 HIV infection diagnoses and 208 deaths among people reported with HIV/AIDS in Massachusetts.
HIV infection diagnoses and deaths among people with HIV/AIDS continue to decline each year, but because infection 
diagnoses continue to exceed the number of deaths annually, the number of people known to be living with HIV/AIDS in
Massachusetts has increased by 30% from 14,391 on December 31, 2003 to 18,698 on December 31, 2012. 
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From 2010 to 2012, of the 2,065 HIV infection
diagnoses in Massachusetts, 1,503 (73%) were
in men and 562 (27%) were in women. Most of
the newly diagnosed HIV infections in men were
in white (non-Hispanic) men, whereas the 
majority of newly diagnosed HIV infections in
women were in black (non-Hispanic) women.
From 2010 to 2012, the primary exposure 
mode reported among HIV infection diagnoses
in Massachusetts was male-to-male sex at
43%, followed by presumed heterosexual 
sex (12%), heterosexual sex (11%), and 
injection drug use (8%). Twenty-two percent 
of diagnoses were reported without adequate
risk information.
Since the mid-1990s, Massachusetts has 
experienced a dramatic reduction in mother-to-
child transmission of HIV infection. From 2003
to 2012, the number of HIV-infected newborns
identified ranged from zero to four. The decline
is attributed to improvements in HIV screening
during pregnancy and the treatment of HIV-
infected women with anti-retroviral therapy.
However, every case of mother-to-child 
transmission remains a sentinel event 
mandating investigation to identify if new systems
can be put in place to assure maximum efforts 
to prevent vertical transmission.
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The number of confirmed cases of chronic 
hepatitis B reported in Massachusetts has been
declining since 2005. In 2013, 368 confirmed
chronic cases were reported. This number is
likely to increase due to continued processing 
of case reports and case confirmation. Even 
so, there is an overall downward trend in both
confirmed and probable cases of hepatitis B 
infection (data not shown), due in large part to 
almost universal immunization of children 
against hepatitis B. Any shifts in testing access
for immigrants from endemic countries may 
also impact these numbers.
Seventy-two confirmed cases of acute hepatitis
B were identified in 2013. Confirmation of 
acute infection requires additional information,
including specific laboratory test results and 
information on symptoms, which are not always
available to MDPH. Furthermore, acute HBV 
infection is often asymptomatic and those 
individuals are consequently unlikely to be aware
of their status and seek care. Thus, the number
of reported confirmed acute cases of hepatitis B
virus infection is likely an underestimate of the
true number of acute cases in the state. 
It is recommended that pregnant women be
screened for hepatitis B during pregnancy to
allow case management to begin early and 
prevent mother-to-child transmission of the virus
to infants. Since 2007, the Perinatal Hepatitis B
Program has partnered with local public health
programs to increase identification of household
and sexual contacts of hepatitis B surface antibody
(HBsAg)-positive pregnant women in an effort 
to reduce transmission of hepatitis B. Babies 
of infected mothers can be protected by 
administration of hepatitis B immune globulin and
hepatitis B vaccine (post-exposure prophylaxis 
or PEP). Uninfected contacts can be vaccinated 
to prevent infection.
PERINATAL HEPATITIS B PROGRAM
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Due to enhanced surveillance focused on
identifying pregnant women who are hepatitis
B positive, a large number of the hepatitis B
cases identified and reported in 2013 were in
women between the ages of 20 and 39 years.
While efforts are made to identify infection
among the household and sexual contacts 
of these women, there are many barriers to
getting those partners tested.
Most newly reported cases of chronic hepatitis 
B are in people living in urban areas such as
Boston, Worcester, Lowell, and Springfield. 
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There has been an overall decline in the number
of newly diagnosed hepatitis C cases reported in
Massachusetts since 2004. However, the overall
number of cases reported remains very high with
7,000 to 10,000 newly diagnosed probable and
confirmed cases reported to MDPH annually
since 2002. There were 5,098 hepatitis C cases
reported to MDPH for 2013 but many reported
cases have yet to be fully processed, so this
number is likely to increase. Hepatitis C virus 
remains one of the highest volume infectious 
diseases reported in Massachusetts. 
A change in the acute hepatitis C case definition
was adopted by the Centers for Disease Control
and Prevention (CDC) in 2013. Formerly, 
rule-out of hepatitis A and B infection was 
required to confirm a case. Due to the difficulty
in obtaining these laboratory results, this led to 
a small number of confirmed acute cases. The 
increase seen in 2013 cases reflects the case
definition change that lifted this requirement.
Acute cases of hepatitis C are reported in
CDC’s annual summary of notifiable diseases,
while chronic hepatitis C is not.
The age distribution of hepatitis C cases reported
in Massachusetts has changed between 2002
and 2013. In 2002 the reported cases were 
distributed in a curve with one age peak around
45 years. In 2013, the reported cases were 
distributed in a bi-modal curve with one peak at
25 years of age and a second at 55 years.
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More hepatitis C cases reported in 2013 are
identified in males than in females in almost all
age groups, except the 15 to 19 year age
group, where the number of females is slightly
higher than males.
Cases of hepatitis C are reported in communities
across Massachusetts, including urban, suburban,
and rural areas of the state.
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In 2013, 64% of chlamydia cases and 43% 
of gonorrhea cases were reported in 
adolescents and young adults (ages 15-24).
From 2010 to 2012, HIV infection diagnoses
among adolescents and young adults in 
Massachusetts had the following racial/ethnic
distribution: white (non-Hispanic) (34%), black
(non-Hispanic) (33%), Hispanic/Latino (27%),
and other (5%).
STDs AND HIV/AIDS IN ADOLESCENTS AND YOUNG ADULTS
Compared to older adults, sexually active adolescents and young adults are at higher risk for 
acquiring STIs because of a combination of behavioral, biological, and cultural factors. The higher
prevalence of STIs among adolescents may also reflect multiple barriers to accessing quality STD
prevention services, including lack of insurance/unwillingness to use parents’ insurance due to
confidentiality concerns, lack of other ability to pay for services in the absence of insurance, lack
of transportation, discomfort with facilities and services designed for adults, and concerns about
confidentiality. (Source: CDC. Sexually Transmitted Disease Surveillance, 2012. Atlanta: U.S. 
Department of Health and Human Services; 2014.)
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From 2010 to 2012, the primary mode of 
exposure for HIV infection diagnoses in 
adolescents and young adults was male-
to-male sex (58%), followed by presumed 
heterosexual sex (10%), heterosexual sex 
and MSM/IDU (both 6%), and injecting drug
use (4%). Fifteen percent of adolescents 
and young adults were reported with no 
risk information.
The Youth Risk Behavior Survey (YRBS) is performed biennially among a sample of
9th to 12th grade students. A review of data provided from the Massachusetts YRBS
over the past two decades indicates that three indicators of youth sexual behavior
(ever having had sex, first sex before age 13 years, and four or more lifetime sexual
partners) reached their lowest levels at the time in 2003 (respectively 41%, 5%, and
10%), and after slight increases of potential concern in 2009, decreased below 2003
levels (to 38%, 3%, and 9% in 2013). In contrast, two correlates of protective sexual
behaviors, use of condoms at last sex and being taught about HIV/AIDS in school,
have shown declines from previous gains (respectively 58% in 2013 down from 65%
in 2005, and 85% in 2013 down from 93% in 2005).
REPORTED SEXUAL BEHAVIORS AMONG MASSACHUSETTS HIGH
SCHOOL STUDENTS, 2003–2013
AFFIRMATIVE RESPONSES (percent)
2003 2005 2007 2009 2011 2013
Lifetime sexual intercourse 41 45 44 46 42 38
Sexual intercourse before age 13 5 5 6 5 4 3
Four or more lifetime sexual partners 10 13 12 13 11 9
Condom use at last sexual intercourse 57 65 61 58 58 58
Ever taught in school about AIDS or HIV 92 93 89 87 84 85
Data source: Massachusetts Department of Elementary and Secondary Education, Massachusetts Youth Risk Behavior Survey
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Unlike gonorrhea, chlamydia infection in
Massachusetts is more commonly reported
in women. From 2004 to 2013, the number 
of chlamydia cases in women increased 
by 80%, in part due to increased adoption 
of routine screening by Massachusetts
healthcare providers, as recommended 
by the Centers for Disease Control 
and Prevention.
In 2013, women were over-represented among
chlamydia cases by a ratio of 2.2 to 1. The
greater number of chlamydia cases in women 
is attributable in part to increased screening 
in women as compared to men.
From 2012 to 2013, the number of gonorrhea
cases among females increased by 9% (from
1,086 to 1,180) while the number of cases
among males increased by 25% (from 1,578 
to 1,965).
STDs AND HIV/AIDS IN WOMEN
In women, untreated STIs can lead to serious health consequences including pelvic inflammatory
disease, infertility, ectopic pregnancy, and cervical cancer. Women are disproportionately impacted
by STI complications because STIs are more likely to remain undetected, delaying treatment.
While women are highly susceptible to infection anatomically, they are less likely to have symptoms
and if they do exhibit symptoms, more likely to attribute them to something else. (Source: CDC.
CDC Fact Sheet, 10 Ways STDs Impact Women Differently from Men. April 2011. Available at:
http://www.cdc.gov/nchhstp/newsroom/docs/STDs-Women-042011.pdf.)
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From 2010 to 2012, the exposure modes for the
562 HIV infection diagnoses reported in women
in Massachusetts were attributed to presumed
heterosexual sex (45%), heterosexual sex
(27%), injection drug use (12%), and other 
exposure modes (1%). Fifteen percent of
women were reported with no identified risk 
for HIV exposure.
From 2010 to 2012, 53% of women diagnosed
with HIV infection were born outside of the U.S.
For men diagnosed from 2010 to 2012, only
26% were born outside of the U.S.
Eighty-five percent of women diagnosed with
HIV infection who were born outside of the 
U.S. were born in regions of the world where
heterosexual sex is the predominant mode 
of transmission of HIV infection.
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Although communities of color represent only
25% of the total Massachusetts population,
these communities bear a disproportionate
burden of STIs. In 2013, 46% of infectious
syphilis cases, 61% of gonorrhea cases, 
and 59% of chlamydia cases occurred in 
individuals from communities of color.
From 2010 to 2012, the racial/ethnic distribution
of HIV infection diagnoses in Massachusetts
was: white (non-Hispanic) (38%), black 
(non-Hispanic) (32%), Hispanic/Latino (26%),
and other/unknown (4%).
RACIAL/ETHNIC DISPARITIES IN STDs AND HIV/AIDS
As stated in the 2012 Sexually Transmitted Disease Surveillance Report from the Centers for 
Disease Control and Prevention (CDC), national surveillance data show higher rates of reported
STIs among some racial or ethnic minority groups when compared with rates among white 
residents. Race and ethnicity in the United States are risk markers that correlate with other more
fundamental determinants of health status such as poverty, unemployment, low educational 
attainment, access to quality health care, and living in communities with high prevalence of STDs.
“Acknowledging the inequity in STD rates by race or ethnicity is one of the first steps in empowering
affected communities to organize and focus on this problem.” (Source: CDC. Sexually Transmitted
Disease Surveillance, 2012. Atlanta: U.S. Department of Health and Human Services; 2014.)
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In Massachusetts, in 2014, the prevalence rate
of people living with HIV/AIDS was highest
among the black (non-Hispanic) and Hispanic/
Latino populations. As compared to the white
(non-Hispanic) population, the rate of people 
living with HIV/AIDS was ten times higher
among the black (non-Hispanic) population and
seven times higher among the Hispanic/Latino
population.
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In 2013, 536 infectious syphilis cases were 
reported in MSM in Massachusetts, of which
42% (N=223) were in Suffolk County.
The percentage of infectious syphilis cases that
were among MSM increased from 29% in 2004
to 73% in 2013. During this time period the
number of reported cases among MSM more
than tripled, from 152 to 536.
The racial/ethnic distribution of infectious
syphilis cases reported in 2013 among MSM
was: white (non-Hispanic) (56%), black 
(non-Hispanic) (15%), Hispanic/Latino (19%),
and other (6%). An additional 3% of cases 
were reported with unknown race/ethnicity. 
The median age of infectious syphilis cases 
reported among MSM was 35 years.
STDs AND HIV/AIDS IN MEN WHO HAVE SEX WITH MEN
Notifiable disease surveillance data on syphilis and data from the National Gonococcal Isolate
Surveillance Project suggest that some STDs are increasing in MSM, including men who have
sex with both men and women. Because STIs and the behaviors associated with acquiring them
increase the likelihood of acquiring and transmitting HIV infection, the rise in STIs among MSM may
be associated with the increase in HIV diagnosis among MSM. (Source: CDC. Sexually Transmitted
Disease Surveillance, 2012. Atlanta: U.S. Department of Health and Human Services; 2014.)
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In 2013, 43% of the reported infectious
syphilis cases in MSM occurred in individuals
who reported they were HIV-positive.
Among males, the proportion of reported HIV 
infection cases with male-to-male sex as the 
reported mode of exposure increased from 
49% in 2003 to 61% in 2012.
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SUMMARY OF STRENGTHS AND LIMITATIONS OF DATA
HIV/AIDS Case Data
• Collected by MDPH 
Bureau of Infectious 
Disease, HIV/AIDS 
Surveillance Program.
• Reportable statewide.
• All licensed healthcare 
providers are required 
by law to report. 
• HIV infection and 
AIDS cases are reported 
by name.
• Individuals diagnosed 
out of state have been 
excluded in analysis.
• Statewide reporting, 
population-based.
• Risk information is 
available. 
• Completeness of 
reporting is high.
• Comparable with other 
states.
• Under-reporting 
(10%–15%) hampers 
interpretation of HIV/AIDS
case data.
• Not all HIV/AIDS cases 
are reported at time of 
diagnosis (reporting lag).
• HIV/AIDS data may be 
incomplete because 
some HIV-infected people
may not have been 
tested or have entered 
care.
STD Case Data
• Collected by MDPH 
Bureau of Infectious 
Disease, Division of 
STD Prevention. 
• Reportable statewide.
• All laboratories and 
healthcare providers are 
required by law to report 
STIs (including syphilis, 
gonorrhea, chlamydia 
infection, lymphoma 
granuloma venereum, 
chancroid, granuloma 
inguinale, neonatal 
herpes infection).
• Statewide reporting, 
population-based.
• Comparable with other 
states.
• Enhanced reporting of 
positive laboratory results.
• Under-reporting of up to 
10% of STD cases.
• Race/ethnicity is missing 
in 34% of chlamydia, 25% 
of gonorrhea and 6% of 
infectious syphilis cases.
• Bias is introduced for 
some STDs, such as 
chlamydia infection, 
where screening of 
asymptomatic persons 
occurs more frequently 
in women than in men.
Viral Hepatitis Case Data
• Collected by MDPH 
Bureau of Infectious 
Disease, Office of 
Integrated Surveillance 
and Informatics Services.
• Reportable statewide.
• All laboratories and 
healthcare providers are 
required to report cases, 
or laboratory indicators, 
of hepatitis B and C 
infection.
• Statewide reporting, 
population-based.
• Enhanced reporting of 
acute cases, hepatitis B 
cases in child-bearing 
aged women and children
and hepatitis C infection 
among cases ages 15–25.
• Race data are missing in 
24% of confirmed chronic 
hepatitis B and 41% of 
confirmed hepatitis C 
cases in 2013; ethnicity 
data are missing in 40% 
of confirmed chronic 
hepatitis B and 59% of 
confirmed hepatitis C 
cases in 2013.
• Risk history data is 
missing in a majority of 
reported hepatitis B and 
C cases.
Description
Strengths
Limitations
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INTERPRETING STD AND HIV/AIDS DATA
All viral hepatitis data reported are current as of June 11, 2014, all HIV/AIDS data are as of January 1, 2014,
and all STD data are as of June 27, 2014. 
I. HIV/AIDS Exposure Mode Definitions
The HIV/AIDS exposure mode indicates the most probable risk behavior associated with HIV infection. 
Assignment of exposure mode is done in accordance with Centers for Disease Control and Prevention
guidelines when multiple exposure modes are reported. Following is a description of the exposure mode 
categories:
• MSM (Male to Male Sex): Includes men who report sexual contact with other men, and men who report 
sexual contact with both men and women. Please note the acronym MSM is also used to refer to “men 
who have sex with men”.
• IDU (Injection Drug Use): Cases in persons who report injection drug use.
• MSM/IDU: Cases in men who report both injection drug use and sexual contact with other men.
• Heterosexual Sex: Cases in persons who report specific heterosexual sex with a person with, or at 
increased risk for, HIV infection (e.g. an injection drug user). The sub-categories for this mode of 
transmission are listed below.
- Heterosexual Sex w/ an Injection Drug User
- Heterosexual Sex w/ a person w/ HIV infection or AIDS
- Heterosexual Sex w/ Bisexual male
- Other Heterosexual Sex: Includes all other sub-categories of risk, such as heterosexual contact with a 
person infected through a blood transfusion.
• Presumed Heterosexual: Cases among females who report heterosexual sex but do not report any other 
personal risk or any knowledge of specific risk in their male sex partners. As of January 1, 2011, males 
that were previously grouped in this category are categorized as No Identified Risk. Presumed 
Heterosexual is an exposure mode category used by the Massachusetts HIV/AIDS Surveillance Program. 
The Centers for Disease Control and Prevention (CDC) categorizes these cases as No Identified Risk.
• Pediatric: Infection before the age of 13 years, including mother to child transmission through pregnancy, 
childbirth or breastfeeding and blood transfusions to children.
• NIR (No Identified Risk): Cases in persons with no reported history of exposure to HIV through any of 
the listed exposure categories. Follow-up is conducted to determine risk for those cases that are initially 
reported without a risk identified. Includes cases among men who were previously categorized as 
Presumed Heterosexual.
II. References to Newly Diagnosed HIV Infections
Due to reporting delays related to site-specific reporting issues, all HIV/AIDS data reflect HIV diagnosed
through 2012. Newly diagnosed HIV infections/cases include all persons diagnosed with HIV in 2012, 
including those who were concurrently or subsequently diagnosed with AIDS. 
III. Race/Ethnicity of STD and HIV/AIDS Cases
Race/ethnicity references to white residents and black residents represent persons who are white non-
Hispanic and black non-Hispanic, respectively. All references to Hispanic/Latino for race/ethnicity represent
persons of Hispanic/Latino heritage regardless of race. 
IV. STD Case Reports and Analyses
All information on STD cases reflect year of report and all incidence calculations represent crude rates. The
source of denominators for calculating rates was the Annual Estimates of the Resident Population for Selected
Age Groups by Sex for the United States, States, Counties, and Puerto Rico Commonwealth and Municipios:
April 1, 2010 to July 1, 2013; Source: U.S. Census Bureau, Population Division; Release Date: June 2014 and
Table 2. Intercensal Estimates of the Resident Population by Sex and Age for Massachusetts: April 1, 2000 to
July 1, 2010 (ST-EST00INT-02-25); Source: U.S. Census Bureau, Population Division; Release Date: October
2012. The distribution of STD cases with unknown race/ethnicity has changed from previous issues of this 
report: cases with unknown race/ethnicity are now removed from the analyses instead of redistributed. Due 
to this change, STD incidence rates by race/ethnicity are lower for all years than previously reported. 
V. Cell Suppression Methodology of STD and HIV/AIDS Data
Values less than five are suppressed for populations less than 50,000 or for unknown values. Additional 
values may be suppressed to prevent back calculation.
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Policy Development 
and Administration
Sylvie Ratelle STD/HIV 
Prevention Training 
Center
STD/HIV/AIDS 
Surveillance and 
Epidemiology
STD Clinical Services 
STD Disease Intervention Field
Services and STD 
Partner Notification
STD Health Education, 
Training, and Prevention
Policy, Planning, 
Resource Allocation, 
Capacity Building, 
Administration and 
Finance, Personnel, 
Contracts and 
Procurement, Budget
Population Health and 
Community Engagement, 
Consumer Office
Medical Case Management 
and Health Related Support 
Services, Prevention and 
Screening, Contracts 
Viral Hepatitis Programs
Viral Hepatitis Surveillance 
and Epidemiology
Brenda Cole (STD Division Director)
Katherine Hsu (Medical Director)
Janine Dyer (Deputy Director)
Betsey John (Director, HIV/AIDS 
and STD Surveillance)
Katherine Hsu (Medical Director)
Barbara Coughlin (Public Health Nurse)
David Goudreau
(Field Operations Manager)
Brenda Hernandez 
(Special Projects Coordinator)
Laura Smock (IPP Coordinator)
Dawn Fukuda (Director, Office of
HIV/AIDS)
Tammy Goodhue (Director of Capacity
Building and Health Communications)
Bob Carr (Deputy Bureau Director)
Ceci Dunn (Director of Disease 
Response Systems)
Cheryl Bernard (Director of 
Administration and Finance)
Terry McCue (Contracts and 
Procurement Director)
Nadia ElKamouss 
(Fiscal Director)
Barry Callis 
(Director of Behavioral Health and
Infectious Disease Prevention)
Paul Goulet 
(Director of Consumer Office)
Tammy Goodhue (Director of Capacity
Building and Health Communications)
Linda Goldman
(Director of Health Program 
and Disease Prevention)
Daniel Church (Viral Hepatitis 
Prevention Coordinator, Division of
Epidemiology and Immunization)
Kerri Barton (Epidemiologist)
Shauna Onofrey (Viral Hepatitis
Surveillance Coordinator)
BrendaCole@state.ma.us
Katherine.Hsu@state.ma.us
Janine.Dyer@state.ma.us
Betsey.John@state.ma.us
Katherine.Hsu@state.ma.us
Barbara.Coughlin@state.ma.us
David.Goudreau@state.ma.us
Brenda.Hernandez@state.ma.us
Laura.Smock@state.ma.us 
Dawn.Fukuda@state.ma.us
Tammy.Goodhue@state.ma.us
Bob.Carr@state.ma.us
Ceci.Dunn@state.ma.us
Cheryl.Bernard@state.ma.us
Terry.McCue@state.ma.us
Nadia.ELKamouss@state.ma.us
Barry.Callis@state.ma.us
Paul.B.Goulet@state.ma.us
Tammy.Goodhue@state.ma.us
Linda.Goldman@state.ma.us
Daniel.Church@state.ma.us
Kerri.Barton@state.ma.us
Shauna.Onofrey@state.ma.us
Topic Contact Email
Office of HIV/AIDS
Viral Hepatitis Program
617-983-6941
617-983-6948
617-983-6964
617-983-6570
617-983-6948
413-586-7525
617-983-6835
617-983-6943
617-983-6961
617-624-5303
617-624-5338
617-624-5317
617-624-5370
617-624-5355
617-624-5858
617-624-5352
617-624-5316
617-624-5389
617-624-5338
617-624-5347
617-983-6830
617-983-6876
617-983-6776
Phone
Division of STD Prevention & HIV/AIDS Surveillance, and Ratelle STD/HIV Prevention Training Center
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STD, HIV/AIDS AND VIRAL HEPATITIS RESOURCES
Type of Training
STD Education, STD Partner Notification, 
and STD Reporting 
HIV/AIDS Reporting and 
Surveillance Projects
HIV/AIDS Provider Trainings
Viral Hepatitis Education
STD/HIV Diagnosis, Treatment, 
and Management
Material and Clinical Toolkits
Type of Material
STD, HIV, Viral Hepatitis Fact Sheets
HIV/AIDS Reporting for Health Care 
Providers Brochure
Viral Hepatitis Posters and Brochures
STD/HIV Diagnosis, Treatment, and 
Management Toolkits
MDPH and MDPH Funded Websites
Contact Information and Website
617-983-6940
www.mass.gov/dph/cdc/std
617-983-6560
www.mass.gov/dph/cdc/aids
617-624-5338
www.mass.gov/dph/aids
617-983-6830
http://www.mass.gov/eohhs/consumer/wellness/disease-
prevention/communicable-diseases/hepatitis/hepatitis-
c/viral-hepatitis-educational-materials.html  
617-983-6945
www.RatellePTC.org
Contact Information and Website
617-983-6940
http://www.mass.gov/eohhs/gov/departments/dph/
prog-a-j/bcdc/factsheets.html 
617-983-6560
www.mass.gov/eohhs/provider/reporting-to-state/
diseases-and-conditions/hiv-aids/hiv-reporting-in-mass-
for-health-care-providers.html 
617-983-6800
http://www.maclearinghouse.com/category/HEP.html 
617-983-9645
www.RatellePTC.org
Training
Professional training to community based organizations, local public health departments, and medical
providers can be requested and is free of charge. 
Division of STD Prevention www.mass.gov/dph/cdc/std
HIV/AIDS Bureau www.mass.gov/dph/aids
HIV/AIDS Surveillance www.mass.gov/dph/cdc/aids
Viral Hepatitis Program www.mass.gov/hepc
Sylvie Ratelle STD/HIV Prevention Training Center www.RatellePTC.org
National Websites 
Center for Disease Control and Prevention www.cdc.gov
Division of STD Prevention www.cdc.gov/std
Division of HIV/AIDS Prevention www.cdc.gov/hiv
Division of Viral Hepatitis www.cdc.gov/ncidod/diseases/hepatitis
National Network of STD/HIV Prevention 
Training Centers www.nnptc.org
CDC funded viral hepatitis online training http://depts.washington.edu/hepstudy/ 
Health education materials and clinical toolkits can be requested free of charge.
